| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MAXCYTE, INC. | Director | Common Stock | 21.4K | $105K | $4.90 | Jun 11, 2024 | Direct |
| ALX ONCOLOGY HOLDINGS INC | Director | Common Stock | 33K | $51K | $1.55 | Dec 2, 2024 | Direct |
| MAXCYTE, INC. | Director | Stock Option (right to buy) | 40.7K | Jun 11, 2024 | Direct | ||
| BioAge Labs, Inc. | Director | Stock Option (Right to Buy) | 28.5K | Apr 17, 2024 | Direct | ||
| ALX ONCOLOGY HOLDINGS INC | Director | Stock Option (right to buy) | 20.2K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HOLDINGS INC | Dec 2, 2024 | 1 | $46.4K | 4 | Dec 4, 2024 | Director |
| BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Director |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| MXCT | MAXCYTE, INC. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
| BIOA | BioAge Labs, Inc. | Apr 17, 2024 | 2 | $0 | 4 | Sep 27, 2024 | Director |
| MXCT | MAXCYTE, INC. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Jun 20, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| MXCT | MAXCYTE, INC. | Mar 20, 2023 | 1 | $0 | 4 | Mar 21, 2023 | Director |
| MXCT | MAXCYTE, INC. | Jun 29, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| MXCT | MAXCYTE, INC. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Director |
| MXCT | MAXCYTE, INC. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |